EU project to launch five RFID pilot tests

Following a year of research and development, the EU-funded BRIDGE project is now preparing five pilots to test Electronic Product Code (EPC) and Radio Frequency Identification (RFID) technologies.

The pilots, scheduled to start in September, will test RFID across several sectors of industry including retail, pharmaceutical, manufacturing, distribution and logistics, and services.

The Electronic Product Code (EPC) is a family of coding schemes created to succeed the bar code. It was created as a low-cost method of tracking goods using RFID technology. RFID is a method of identifying unique items using radio waves. Typically, a reader communicates with a tag, which holds digital information in a microchip.

BRIDGE (Building Radio frequency IDentification solutions for the Global Environment) is a three-year €7.5 million project funded under the EU's Sixth Framework Programme (FP6). It is made up of a consortium of 30 partners from the worlds of industry and research.

BRIDGE was created to research, develop and implement tools enabling RFID and EPCglobal applications, as well as to drive the acceptance of EPCglobal standards in Europe.

The first pilot to go live will test the use of EPC second-generation technology to track pallets of pharmaceutical products as they move through the supply chain, from the manufacturers through distributor networks and on to hospitals and pharmacies.

"The purpose of the pilot is to use RFID to know where the goods come from, and where they are at any given moment," said Henri Barthel, the coordinator of the BRIDGE project. "With RFID, the idea is that the technology can help companies manage the supply chain in a much more accurate and efficient manner."

The pilot will aim to trace a number of products, identified at the carton and pallet levels using EPC RFID tags and 2-D bar-code labels. According to the organisers, deploying this 'hybrid environment' of RFID and bar-coding will afford them the chance to discover the pros and cons of each technology. In addition to RFID tags and 2-D bar-code labels, the pilot will incorporate a network-based system allowing the participants in the project to store, access and analyse all data collected during the experiment.

Ultimately, the objective of the pilot will be to increase the safety of patients by improving the traceability of pharmaceutical products and certifying the pedigree or authenticity of these as they move from the manufacturer to the final user.

Another pilot will be in the retail sector where BRIDGE will test the use of second generation EPC RFID to track cartons and pallets of clothing from the point of manufacture to the store. The pilot will track the goods as they move across the supply chain, but could also include novel in-store applications such as using RFID tags to identify individual garments, and installing RFID interrogators in dressing rooms so shoppers could obtain detailed product information about the items they are trying on, such as sizes, prices and availability.

Lastly, three more similar pilots will take place in food manufacturing processes, reusable assets and products in-service. The results of all five pilots will be made available by the project as it seeks to promote the uptake of standardised EPC and RFID technology for use in global supply chains.

"Since its inception, RFID has been hailed as the panacea for a more sophisticated and efficient global supply chain," said Mr Barthel. "The BRIDGE project will transform RFID from being an identification technology into providing an EPCglobal based product information network."

For further information, please visit:
http://www.bridge-project.eu

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...